menu
    • menu

    Company profile for DICE Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At DICE Therapeutics, we design and develop innovative therapies in immunology for patients with chronic diseases. Seeking to create a future where convenient oral medicines with biologic-like efficacy are available to patients with serious medical conditions, we are developing oral alternatives to medicines currently limited to injectable forms.The combination of our core technology with additional, unique biophysical insight...
    At DICE Therapeutics, we design and develop innovative therapies in immunology for patients with chronic diseases. Seeking to create a future where convenient oral medicines with biologic-like efficacy are available to patients with serious medical conditions, we are developing oral alternatives to medicines currently limited to injectable forms.The combination of our core technology with additional, unique biophysical insights has enabled DICE to target protein-protein interactions with small molecules. In doing so, DICE has cracked open a previously intractable set of clinically validated therapeutic targets

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    DICE TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    279 E. Grand Avenue, Suite 300, Lobby B South San Francisco, CA 94080
    Telephone
    Telephone
    650.566.1402
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.dicetherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dice-therapeutics?
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lilly changes lead psoriasis program from $2.4B Dice buyout
    Lilly changes lead psoriasis program from $2.4B Dice buyout

    30 Oct 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/eli-lilly-rolls-dice-axing-psoriasis-prospect-and-pivoting-follow-1-year-after-24b-buyout

    FIERCE BIOTECH
    30 Oct 2024
    Share Share
    Lilly Completes Acquisition of DICE Therapeutics
    Lilly Completes Acquisition of DICE Therapeutics

    09 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lilly-completes-acquisition-of-dice-therapeutics-301896892.html

    PR NEWSWIRE
    09 Aug 2023
    Share Share
    Lilly Announces Extension of Tender Offer to Acquire DICE
    Lilly Announces Extension of Tender Offer to Acquire DICE

    25 Jul 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lilly-announces-extension-of-tender-offer-to-acquire-dice-301884518.html

    PR NEWSWIRE
    25 Jul 2023
    Share Share
    Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology
    Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology

    21 Jun 2023

    // PRESS RELEASE

    https://investor.lilly.com/news-releases/news-release-details/lilly-acquire-dice-therapeutics-advance-innovation-immunology

    PRESS RELEASE
    21 Jun 2023
    Share Share
    DICE Therapeutics to Host R&D Investor Event on Tuesday, June 20, 2023
    DICE Therapeutics to Host R&D Investor Event on Tuesday, June 20, 2023

    13 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/13/2687647/0/en/DICE-Therapeutics-to-Host-R-D-Investor-Event-on-Tuesday-June-20-2023.html

    GLOBENEWSWIRE
    13 Jun 2023
    Share Share
    DICE Therapeutics Reports First Quarter 2023 Financial Results
    DICE Therapeutics Reports First Quarter 2023 Financial Results

    11 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/11/2667305/0/en/DICE-Therapeutics-Reports-First-Quarter-2023-Financial-Results-and-Recent-Highlights.html

    GLOBENEWSWIRE
    11 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search